Search alternatives:
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13041
Activation of deep SC neurons recapitulates delayed LER in <i>Setd5</i><sup><i>+/−</i></sup> animals.
Published 2024“…(<b>I</b>) Proportion of trials at different laser intensities that either show an increase (white), decrease (black), or no change (grey) in speed upon light activation for <i>Setd5</i><sup>+/+</sup> (top) and <i>Setd5</i><sup>+/<i>−</i></sup> (bottom). 0.01 mW mm<sup>−2</sup>: 35 trials, <i>p</i> = 0.649; 0.5 mW mm<sup>−2</sup>: 111 trials, <i>p</i> = 0.193; 5 mW mm<sup>−2</sup>: 50 trials, <i>p</i> < 0.001; 10 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001; 15 mW mm<sup>−2</sup>: 61 trials, <i>p</i> = 0.004; 20 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001, X<sup>2</sup> test of independence. …”
-
13042
-
13043
-
13044
-
13045
Directed evolution of HIV-1 to utilize CD4<sup>low</sup> target cells.
Published 2017“…<b>(E)</b> Adaptation to CD4<sup>low</sup> target cells results in high resistance to CD4 inhibitor compared to wild type HIV-1 isolates. Comparison of IC50 of CD4-blocking DARPin 55.2 against 41 wild-type HIV-1 strains from different clades (black dots, see <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006255#ppat.1006255.s003" target="_blank">S3 Table</a> for details on virus panel and individual IC50 values) and the CD4<sup>low</sup> adaptation virus panel (colored dots, see legend) probed by Env pseudovirus infection on TZM-bl cells. …”
-
13046
-
13047
-
13048
-
13049
-
13050
-
13051
Dysregulated alternative splicing in DM1 hiNeurons at 10 DPI.
Published 2022“…(d) Scatter plots pertaining to Fig 5c show decreased inclusion of <i>MAPT</i> e2 (top), <i>CSNK1D</i> e9 (bottom left) and <i>MPRIP</i> e9 (bottom right) in DM1 hiNeurons. …”
-
13052
-
13053
Efficacy of R-LM113 and R-115 administered early after tumor implantation on the growth of HER2-LLC1 tumors.
Published 2018“…The mice decreased in number because of deaths caused by the primary tumor. …”
-
13054
-
13055
-
13056
-
13057
-
13058
-
13059
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip...
Published 2021“…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”
-
13060
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip...
Published 2021“…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”